OPNT Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 25.15%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Opiant Pharmaceuticals Share Price & Price History
Current Price: $20.65
Price Change: +0.30 (1.20%)
As of 03/2/2023 01:00 AM ET
Opiant Pharmaceuticals Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/27/2023 | Brian Gorman | General Counsel | Sell | 444 | $20.26 | $8,995.44 | 31,990 |  |
| 1/27/2023 | David D. O'Toole | CFO | Sell | 541 | $20.26 | $10,960.66 | 34,248 | |
| 1/27/2023 | Mark Jason Heath Ellison | Insider | Sell | 610 | $20.26 | $12,358.60 | 18,751 | |
| 1/27/2023 | Roger Crystal | CEO | Sell | 1,358 | $20.26 | $27,513.08 | 75,339 | |
| 1/9/2023 | David D. O'Toole | CFO | Sell | 415 | $20.20 | $8,383.00 | 34,789 | |
| 1/9/2023 | Mark Jason Heath Ellison | Insider | Sell | 469 | $20.20 | $9,473.80 | 19,361 | |
| 1/9/2023 | Roger Crystal | CEO | Sell | 1,183 | $20.20 | $23,896.60 | 76,697 | |
| 1/5/2023 | Brian Gorman | General Counsel | Sell | 1,313 | $20.20 | $26,522.60 | 32,434 | |
| 1/5/2023 | David D. O'Toole | CFO | Sell | 1,600 | $20.20 | $32,320.00 | 35,204 | |
| 1/5/2023 | Mark Jason Heath Ellison | Insider | Sell | 1,806 | $20.20 | $36,481.20 | 19,830 | |
| 1/5/2023 | Roger Crystal | CEO | Sell | 5,029 | $20.20 | $101,585.80 | 77,880 | |
Opiant Pharmaceuticals Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/15/2023 | Fifth Lane Capital LP | 15,000 | $0.30M | 0.3% | N/A | 0.291% |  |
| 2/14/2023 | CSS LLC IL | 61,349 | $1.24M | 0.1% | N/A | 1.189% | |
| 2/13/2023 | Gamco Investors INC. ET AL | 10,000 | $0.20M | 0.0% | N/A | 0.194% | |
| 2/13/2023 | Ramius Advisors LLC | 55,298 | $1.12M | 1.1% | N/A | 1.071% | |
| 2/10/2023 | New York Life Investment Management LLC | 61,912 | $1.26M | 0.0% | N/A | 1.200% | |
| 2/10/2023 | Yakira Capital Management Inc. | 54,371 | $1.10M | 0.2% | N/A | 1.054% | |
| 1/25/2023 | Lindbrook Capital LLC | 2,000 | $41K | 0.0% | +300.0% | 0.039% | |
| 11/15/2022 | Parkman Healthcare Partners LLC | 76,530 | $0.82M | 0.2% | +1.2% | 1.482% | |
| 11/15/2022 | Essex Investment Management Co. LLC | 47,169 | $0.51M | 0.1% | -6.4% | 0.914% | |
| 10/26/2022 | Mesirow Financial Investment Management Inc. | 17,633 | $0.19M | 0.9% | N/A | 0.342% | |
| 8/12/2022 | Apis Capital Advisors LLC | 196,000 | $2.35M | 2.6% | +75.0% | 3.858% | |
| 8/12/2022 | Essex Investment Management Co. LLC | 50,405 | $0.60M | 0.1% | +57.3% | 0.992% | |
| 7/8/2022 | HealthInvest Partners AB | 210,000 | $2.52M | 5.8% | +1,066.7% | 4.134% | |
| 5/13/2022 | Parkman Healthcare Partners LLC | 32,557 | $0.70M | 0.2% | +4.0% | 0.641% | |
| 5/13/2022 | Apis Capital Advisors LLC | 112,000 | $2.40M | 2.9% | +1.8% | 2.205% | |
| 5/13/2022 | DLD Asset Management LP | 20,000 | $0.43M | 0.0% | -33.3% | 0.394% | |
| 5/12/2022 | Acadian Asset Management LLC | 116,478 | $2.49M | 0.0% | +62.0% | 2.293% | |
| 5/11/2022 | Ovata Capital Management Ltd | 117,865 | $2.53M | 0.8% | N/A | 2.320% | |
| 5/9/2022 | Essex Investment Management Co. LLC | 32,040 | $0.69M | 0.1% | +2.5% | 0.631% | |
| 5/5/2022 | HealthInvest Partners AB | 18,000 | $0.39M | 0.6% | N/A | 0.354% | |
| 4/25/2022 | Bailard Inc. | 15,042 | $0.32M | 0.0% | -7.4% | 0.296% | |
| 2/22/2022 | DLD Asset Management LP | 30,000 | $1.01M | 0.0% | N/A | 0.636% | |
| 2/15/2022 | DLD Asset Management LP | 30,000 | $1.01M | 0.1% | N/A | 0.636% | |
| 2/11/2022 | Renaissance Technologies LLC | 183,815 | $6.18M | 0.0% | -10.6% | 3.894% | |
| 2/10/2022 | Essex Investment Management Co. LLC | 31,263 | $1.05M | 0.1% | +26.1% | 0.662% | |
| 2/10/2022 | Acadian Asset Management LLC | 71,916 | $2.42M | 0.0% | +11.6% | 1.524% | |
| 2/9/2022 | Dimensional Fund Advisors LP | 66,651 | $2.24M | 0.0% | +51.1% | 1.412% | |
| 2/7/2022 | Hillsdale Investment Management Inc. | 3,200 | $0.11M | 0.0% | N/A | 0.068% | |
| 2/3/2022 | Advisor Group Holdings Inc. | 8,125 | $0.27M | 0.0% | +28.5% | 0.172% | |
| 1/27/2022 | Dorsey Wright & Associates | 2,138 | $72K | 0.0% | N/A | 0.045% | |
| 1/19/2022 | Marquette Asset Management LLC | 5,180 | $0.17M | 0.0% | -34.8% | 0.110% | |
| 11/16/2021 | Two Sigma Advisers LP | 83,100 | $2.14M | 0.0% | N/A | 1.889% | |
| 11/16/2021 | Two Sigma Investments LP | 51,045 | $1.31M | 0.0% | N/A | 1.160% | |
| 11/12/2021 | Renaissance Technologies LLC | 205,615 | $5.29M | 0.0% | +7.5% | 4.673% | |
| 11/12/2021 | Apis Capital Advisors LLC | 102,000 | $2.63M | 2.5% | +21.4% | 2.318% | |
| 11/12/2021 | Parkman Healthcare Partners LLC | 30,000 | $0.77M | 0.2% | N/A | 0.682% | |
| 11/12/2021 | Geode Capital Management LLC | 50,244 | $1.29M | 0.0% | +290.0% | 1.142% | |
| 11/12/2021 | EAM Investors LLC | 69,046 | $1.78M | 0.3% | N/A | 1.569% | |
| 11/9/2021 | Essex Investment Management Co. LLC | 24,792 | $0.64M | 0.1% | N/A | 0.563% | |
| 11/9/2021 | BlackRock Inc. | 24,686 | $0.64M | 0.0% | +107.2% | 0.561% | |
| 11/5/2021 | Advisor Group Holdings Inc. | 6,325 | $0.16M | 0.0% | +102.4% | 0.144% | |
| 8/17/2021 | Wells Fargo & Company MN | 251,007 | $3.36M | 0.0% | +0.4% | 5.705% | |
Data available starting January 2016
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
Read More on Opiant Pharmaceuticals
Today's Range
Now: $20.65
52 Week Range
Now: $20.65
Volume
N/A
Average Volume
77,920 shs
Market Capitalization
$108.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.84
